342
Views
11
CrossRef citations to date
0
Altmetric
Clinical & Biomarkers

A prospective study on split-hand index as a biomarker for the diagnosis of amyotrophic lateral sclerosis

, , , , & ORCID Icon
Pages 574-583 | Received 29 Feb 2020, Accepted 03 Jun 2020, Published online: 01 Jul 2020
 

Abstract

Objective

To determine the practical diagnostic utility of split-hand index (SI) values calculated from F-wave persistence (SIFP) and the F/M amplitude ratio (SIF/M) for differentiating patients with amyotrophic lateral sclerosis (ALS) from other conditions. Methods: This prospective study recruited consecutive patients from Peking Union Medical College Hospital, China, between June 2019 and December 2019. Patients 18-80 years old who had clinical neuromuscular symptoms affecting the upper limbs and required electrophysiological examinations to aid diagnosis were eligible. Compound muscle action potentials (CMAPs) and F-waves recorded from the abductor pollicis brevis (APB), first dorsal interosseous muscle (FDI), and abductor digiti minimi (ADM) were examined. SIFP and SIF/M were calculated as: SI = (APB × FDI)/ADM. The sensitivity and specificity of SIFP and SIF/M in differentiating ALS from non-ALS conditions were derived using receiver operating characteristic (ROC) curves. Results: A total of 309 participants, comprising 91 (29.4%) with ALS and 218 (70.6%) with other neuromuscular disorders, were enrolled after 54 were excluded. SIFP was significantly reduced and SIF/M increased in the ALS group compared with the non-ALS group (p < 0.001). By ROC curve analysis, an SIFP cutoff of 73.3 showed 85.7% sensitivity and 80.7% specificity for differentiating ALS from non-ALS. SIF/M and SICMAP showed lower sensitivity (67% and 75.8%, respectively, p < 0.001) than SIFP for ALS diagnosis. SIFP and SIF/M combined did not outperform SIFP alone. Conclusion: SIFP could be a sensitive, noninvasive neurophysiological diagnostic marker for ALS patients with affected upper limbs. In particular, an SIFP value of 73.3 might be the optimal cutoff for diagnosing ALS.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Acknowledgements

The authors thank all members of the Department of Neurology and electromyogram room for helping conduct this study. The authors also thank the patients and their families for their kind participation in this study.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Author contributions

ZW and LC designed the study. ZC, QD and YH collected the data. ZW and ML analyzed the data. ML interpreted the data and performed the literature search. ZW wrote the manuscript and created the figures. ML and LC edited the manuscript. LC revised the manuscript and figures.

Additional information

Funding

This work was supported by the National Key Research and Development Program of China under Grant [2016YFC0905103]; the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS) under Grant [2016-12M-1-004]; the Strategic Priority Research Program (Pilot study) ‘Biological basis of aging and therapeutic strategies’ of the Chinese Academy of Sciences under Grant [XDPB10].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.